• Latest Posts

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

What happened this week? CRISPR, Microbiome, Algae in Biotech

Biotech of the week: Effimune, the French Success-story in autoimmune disease

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Zika Virus: Who in Biotech is Working to Stop its Spread?


Finland, France and Harvard Bioprint Brains to Understand the 3D Structure

How we Raised our First Seed Round to Build the Next TechCrunch for Biotech

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease

France’s 3rd Largest Pharma Company Finally Opens up to Biotech Innovation

Meet the CEO of Europe’s Leading Microbiome Biotech

From Belgium: 3D-Bioprinted ‘Waffle’ to Fix Broken Bones